Read More Analyst Ratings News Price Target JP Morgan Maintains Underweight on HBT Finl, Lowers Price Target to $19 By Benzinga Newsdesk Today, 11:53 PM JP Morgan analyst Anthony Elian maintains HBT Finl (NASDAQ:HBT) with a Underweight and lowers the price target from $19.5 to $19. HBT
Read More Analyst Ratings News Price Target Upgrades Morgan Stanley Upgrades Sealed Air to Overweight, Announces $79 Price Target By Benzinga Newsdesk Today, 11:53 PM Morgan Stanley analyst Angel Castillo upgrades Sealed Air (NYSE:SEE) from Equal-Weight to Overweight and announces $79 price target. SEE
Read More Analyst Ratings News Price Target HC Wainwright & Co. Maintains Buy on Celldex Therapeutics, Raises Price Target to $50 By Benzinga Newsdesk Today, 11:53 PM HC Wainwright & Co. analyst Joseph Pantginis maintains Celldex Therapeutics (NASDAQ:CLDX) with a Buy and raises the price target from $36 to $50. CLDX
Read More Analyst Ratings News Price Target Morgan Stanley Maintains Equal-Weight on NuVasive, Lowers Price Target to $54 By Benzinga Newsdesk Today, 11:53 PM Morgan Stanley analyst Drew Ranieri maintains NuVasive (NASDAQ:NUVA) with a Equal-Weight and lowers the price target from $62 to $54. NUVA